Baxter adds to perfusion business
This article was originally published in Clinica
Baxter Healthcare (US) is to acquire Psicor, a provider of cardiovascular perfusion services to US hospitals, for $80 million. A condition of the deal is that Psicor sells its Office Labs subsidiary. "This acquisition strengthens our ability to offer customers a set of 'capitated' or fixed-cost products and services that will help hospitals manage the total cost of open-heart surgery," says Baxter executive vice-president Lester Knight.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.